Replimune Group Inc (REPL)
6.43
-0.29
(-4.32%)
USD |
NASDAQ |
May 17, 16:00
6.43
0.00 (0.00%)
After-Hours: 20:00
Replimune Group Total Liabilities (Quarterly): 113.21M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 113.21M |
| December 31, 2023 | 111.39M |
| September 30, 2023 | 97.23M |
| June 30, 2023 | 89.86M |
| March 31, 2023 | 91.30M |
| December 31, 2022 | 83.20M |
| September 30, 2022 | 52.02M |
| June 30, 2022 | 49.16M |
| March 31, 2022 | 49.96M |
| December 31, 2021 | 47.77M |
| September 30, 2021 | 46.05M |
| June 30, 2021 | 44.70M |
| March 31, 2021 | 44.37M |
| Date | Value |
|---|---|
| December 31, 2020 | 43.00M |
| September 30, 2020 | 52.85M |
| June 30, 2020 | 51.77M |
| March 31, 2020 | 50.38M |
| December 31, 2019 | 52.86M |
| September 30, 2019 | 30.80M |
| June 30, 2019 | 13.39M |
| March 31, 2019 | 16.47M |
| December 31, 2018 | 8.948M |
| September 30, 2018 | 3.78M |
| June 30, 2018 | 97.99M |
| March 31, 2018 | 93.22M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
13.39M
Minimum
Jun 2019
113.21M
Maximum
Mar 2024
60.76M
Average
51.07M
Median
Total Liabilities (Quarterly) Benchmarks
| Esperion Therapeutics Inc | 667.36M |
| Gossamer Bio Inc | 232.64M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 24.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 487.72M |
| Shareholders Equity (Quarterly) | 374.51M |